Posted in | News | Nanomaterials

USPTO Grants Patent for Cereplast’s Biodegradable Nanopolymer Compositions

Cereplast, Inc., a leading manufacturer of proprietary biobased, compostable and sustainable bioplastics, today announced that the United States Patent and Trademark Office (USPTO) has granted the Company patent protection for biodegradable nanopolymer compositions and biodegradable articles made thereof.

USPTO-issued patent 8,389,614 is a significant patent for the company and for the field of biodegradable polymers, as it is the first of its kind. This patent expands Cereplast's growing intellectual property portfolio and protects the composition formulation invented by the Cereplast R&D team.

This patent describes biodegradable compositions including polylactic acid (PLA) and other components, and incorporates nanofillers that improve the physical and thermal properties of the material. Biodegradable materials are known for their thermal and physical limitations, and the newly-patented Cereplast composition improves such properties by introducing nanofillers that are known for improving polymer functions.

Mr. Frederic Scheer Chairman and CEO of Cereplast commented, "Protecting the intellectual property of the Company is a high priority and is an important part of our long-term growth strategy, as is creating new grades of bioplastic resin that expand the properties available to meet the ever-growing needs of the marketplace. This new patent is the first for biodegradable nanopolymer compositions and further establishes Cereplast's role as a leader in the bioplastics industry. Nanopolymers have brought innovation to the traditional plastics industry, and we are proud to have extended their reach to the bioplastics industry."

Source:

http://www.cereplast.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.